XML 23 R11.htm IDEA: XBRL DOCUMENT v3.19.1
SEGMENT INFORMATION
 6 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
SEGMENT INFORMATION
5.
SEGMENT INFORMATION
 
We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to the Consolidated Financial Statements in our annual report on Form 10-K for the fiscal year ended September 30, 2018.
 
 
 
Three Months Ended
March 31,
 
 
Six Months Ended
March 31,
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
Revenue:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service
 
$
8,131
 
 
$
5,030
 
 
$
15,866
 
 
$
9,555
 
Product
 
 
1,213
 
 
 
914
 
 
 
2,103
 
 
 
1,766
 
 
 
$
9,344
 
 
$
5,944
 
 
$
17,969
 
 
$
11,321
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Income (Loss)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service
 
$
877
 
 
$
918
 
 
$
1,513
 
 
$
1,699
 
Product
 
 
30
 
 
 
52
 
 
 
(50
))
 
 
84
 
Corporate
 
 
(1,355
)
 
 
(861
)
 
 
(1,870
)
 
 
(1,662
)
 
 
$
(449
)
 
$
110
 
 
$
(408
)
 
$
121
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
(122
)
 
 
(48
)
 
 
(248
)
 
 
(100
)
Other income
 
 
3
 
 
 
4
 
 
 
4
 
 
 
4
 
Income (loss) before income taxes
 
$
(568
)
 
$
66
 
 
$
(652
)
 
$
25